nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—HTR2C—choroid plexus—brain cancer	0.0875	0.115	CbGeAlD
Propiomazine—HTR2A—choroid plexus—brain cancer	0.0439	0.0575	CbGeAlD
Propiomazine—HRH1—nose—brain cancer	0.0339	0.0444	CbGeAlD
Propiomazine—DRD1—telencephalic ventricle—brain cancer	0.033	0.0432	CbGeAlD
Propiomazine—HTR2C—telencephalic ventricle—brain cancer	0.0256	0.0336	CbGeAlD
Propiomazine—HTR2A—trigeminal nerve—brain cancer	0.0222	0.0291	CbGeAlD
Propiomazine—HTR2A—cerebellar cortex—brain cancer	0.0221	0.029	CbGeAlD
Propiomazine—DRD1—ganglion—brain cancer	0.0205	0.0269	CbGeAlD
Propiomazine—HTR2A—vein—brain cancer	0.02	0.0263	CbGeAlD
Propiomazine—DRD2—telencephalic ventricle—brain cancer	0.0195	0.0255	CbGeAlD
Propiomazine—HTR2C—ganglion—brain cancer	0.0159	0.0209	CbGeAlD
Propiomazine—HTR2A—cranial nerve—brain cancer	0.0158	0.0207	CbGeAlD
Propiomazine—HTR2A—pons—brain cancer	0.0156	0.0205	CbGeAlD
Propiomazine—Trifluoperazine—S100A4—brain cancer	0.0152	0.473	CrCbGaD
Propiomazine—HTR2A—telencephalic ventricle—brain cancer	0.0129	0.0168	CbGeAlD
Propiomazine—DRD2—ganglion—brain cancer	0.0121	0.0159	CbGeAlD
Propiomazine—HTR2A—pineal body—brain cancer	0.0112	0.0146	CbGeAlD
Propiomazine—ADRA1A—hindbrain—brain cancer	0.00939	0.0123	CbGeAlD
Propiomazine—DRD2—hindbrain—brain cancer	0.0092	0.0121	CbGeAlD
Propiomazine—DRD1—brainstem—brain cancer	0.00892	0.0117	CbGeAlD
Propiomazine—ADRA1D—telencephalon—brain cancer	0.00831	0.0109	CbGeAlD
Propiomazine—HTR2A—ganglion—brain cancer	0.008	0.0105	CbGeAlD
Propiomazine—DRD1—telencephalon—brain cancer	0.00792	0.0104	CbGeAlD
Propiomazine—CHRM4—head—brain cancer	0.00741	0.00971	CbGeAlD
Propiomazine—DRD4—brain—brain cancer	0.0071	0.0093	CbGeAlD
Propiomazine—HTR2C—brainstem—brain cancer	0.00693	0.00909	CbGeAlD
Propiomazine—HTR2A—endothelium—brain cancer	0.0069	0.00904	CbGeAlD
Propiomazine—CHRM4—central nervous system—brain cancer	0.00676	0.00886	CbGeAlD
Propiomazine—CHRM2—telencephalon—brain cancer	0.00638	0.00836	CbGeAlD
Propiomazine—HTR2A—blood vessel—brain cancer	0.00636	0.00834	CbGeAlD
Propiomazine—HTR2C—telencephalon—brain cancer	0.00615	0.00806	CbGeAlD
Propiomazine—HTR2A—hindbrain—brain cancer	0.00607	0.00795	CbGeAlD
Propiomazine—CHRM1—telencephalon—brain cancer	0.00581	0.00761	CbGeAlD
Propiomazine—CHRM5—head—brain cancer	0.00579	0.00759	CbGeAlD
Propiomazine—DRD1—midbrain—brain cancer	0.00569	0.00745	CbGeAlD
Propiomazine—ADRA1A—brainstem—brain cancer	0.00538	0.00705	CbGeAlD
Propiomazine—CHRM4—brain—brain cancer	0.00537	0.00704	CbGeAlD
Propiomazine—ADRA1B—head—brain cancer	0.00529	0.00693	CbGeAlD
Propiomazine—CHRM5—central nervous system—brain cancer	0.00529	0.00693	CbGeAlD
Propiomazine—DRD2—brainstem—brain cancer	0.00527	0.00691	CbGeAlD
Propiomazine—ADRA1D—endocrine gland—brain cancer	0.00524	0.00687	CbGeAlD
Propiomazine—CHRM3—telencephalon—brain cancer	0.0052	0.00681	CbGeAlD
Propiomazine—ADRA1D—head—brain cancer	0.00518	0.00678	CbGeAlD
Propiomazine—DRD1—head—brain cancer	0.00493	0.00646	CbGeAlD
Propiomazine—HTR2C—medulla oblongata—brain cancer	0.00483	0.00633	CbGeAlD
Propiomazine—ADRA1B—central nervous system—brain cancer	0.00483	0.00633	CbGeAlD
Propiomazine—ADRA1A—telencephalon—brain cancer	0.00477	0.00626	CbGeAlD
Propiomazine—ADRA1D—central nervous system—brain cancer	0.00472	0.00619	CbGeAlD
Propiomazine—DRD2—telencephalon—brain cancer	0.00468	0.00613	CbGeAlD
Propiomazine—DRD1—central nervous system—brain cancer	0.0045	0.0059	CbGeAlD
Propiomazine—HTR2C—midbrain—brain cancer	0.00442	0.00579	CbGeAlD
Propiomazine—HTR2C—spinal cord—brain cancer	0.00431	0.00565	CbGeAlD
Propiomazine—CHRM5—brain—brain cancer	0.0042	0.0055	CbGeAlD
Propiomazine—CHRM2—endocrine gland—brain cancer	0.00403	0.00528	CbGeAlD
Propiomazine—CHRM2—head—brain cancer	0.00397	0.00521	CbGeAlD
Propiomazine—Diltiazem—CYP2C9—brain cancer	0.00395	0.123	CrCbGaD
Propiomazine—ADRA1B—brain—brain cancer	0.00383	0.00502	CbGeAlD
Propiomazine—HTR2C—head—brain cancer	0.00383	0.00502	CbGeAlD
Propiomazine—DRD2—pituitary gland—brain cancer	0.00381	0.00499	CbGeAlD
Propiomazine—ADRA1D—brain—brain cancer	0.00375	0.00492	CbGeAlD
Propiomazine—HRH1—telencephalon—brain cancer	0.0037	0.00484	CbGeAlD
Propiomazine—CHRM1—endocrine gland—brain cancer	0.00366	0.0048	CbGeAlD
Propiomazine—CHRM2—central nervous system—brain cancer	0.00363	0.00475	CbGeAlD
Propiomazine—CHRM1—head—brain cancer	0.00362	0.00474	CbGeAlD
Propiomazine—DRD1—brain—brain cancer	0.00357	0.00468	CbGeAlD
Propiomazine—HTR2C—central nervous system—brain cancer	0.0035	0.00458	CbGeAlD
Propiomazine—HTR2A—brainstem—brain cancer	0.00348	0.00456	CbGeAlD
Propiomazine—DRD2—midbrain—brain cancer	0.00336	0.0044	CbGeAlD
Propiomazine—CHRM1—central nervous system—brain cancer	0.0033	0.00433	CbGeAlD
Propiomazine—CHRM3—endocrine gland—brain cancer	0.00328	0.0043	CbGeAlD
Propiomazine—CHRM3—head—brain cancer	0.00324	0.00424	CbGeAlD
Propiomazine—HTR2A—telencephalon—brain cancer	0.00309	0.00404	CbGeAlD
Propiomazine—ADRA1A—endocrine gland—brain cancer	0.00301	0.00395	CbGeAlD
Propiomazine—ADRA1A—head—brain cancer	0.00297	0.0039	CbGeAlD
Propiomazine—CHRM3—central nervous system—brain cancer	0.00296	0.00387	CbGeAlD
Propiomazine—DRD2—endocrine gland—brain cancer	0.00295	0.00387	CbGeAlD
Propiomazine—DRD2—head—brain cancer	0.00291	0.00382	CbGeAlD
Propiomazine—CHRM2—brain—brain cancer	0.00288	0.00377	CbGeAlD
Propiomazine—HTR2C—brain—brain cancer	0.00278	0.00364	CbGeAlD
Propiomazine—ADRA1A—central nervous system—brain cancer	0.00271	0.00356	CbGeAlD
Propiomazine—DRD2—central nervous system—brain cancer	0.00266	0.00349	CbGeAlD
Propiomazine—ADRA1A—cerebellum—brain cancer	0.00265	0.00348	CbGeAlD
Propiomazine—CHRM1—brain—brain cancer	0.00262	0.00344	CbGeAlD
Propiomazine—DRD2—cerebellum—brain cancer	0.0026	0.00341	CbGeAlD
Propiomazine—HTR2A—gonad—brain cancer	0.00258	0.00338	CbGeAlD
Propiomazine—HTR2A—pituitary gland—brain cancer	0.00251	0.00329	CbGeAlD
Propiomazine—HTR2A—medulla oblongata—brain cancer	0.00243	0.00318	CbGeAlD
Propiomazine—CHRM3—brain—brain cancer	0.00235	0.00307	CbGeAlD
Propiomazine—Thioridazine—CYP2C9—brain cancer	0.00233	0.0724	CrCbGaD
Propiomazine—HRH1—endocrine gland—brain cancer	0.00233	0.00305	CbGeAlD
Propiomazine—HRH1—head—brain cancer	0.0023	0.00302	CbGeAlD
Propiomazine—Trimipramine—CYP2C9—brain cancer	0.00228	0.0708	CrCbGaD
Propiomazine—HTR2A—midbrain—brain cancer	0.00222	0.0029	CbGeAlD
Propiomazine—Promethazine—CYP2C9—brain cancer	0.0022	0.0681	CrCbGaD
Propiomazine—HTR2A—spinal cord—brain cancer	0.00216	0.00283	CbGeAlD
Propiomazine—Methadone—CYP2C9—brain cancer	0.00216	0.0671	CrCbGaD
Propiomazine—ADRA1A—brain—brain cancer	0.00215	0.00282	CbGeAlD
Propiomazine—Perphenazine—CYP2C9—brain cancer	0.00214	0.0665	CrCbGaD
Propiomazine—DRD2—brain—brain cancer	0.00211	0.00277	CbGeAlD
Propiomazine—HRH1—central nervous system—brain cancer	0.0021	0.00275	CbGeAlD
Propiomazine—HTR2A—endocrine gland—brain cancer	0.00195	0.00255	CbGeAlD
Propiomazine—Promazine—CYP2C9—brain cancer	0.00193	0.0599	CrCbGaD
Propiomazine—HTR2A—head—brain cancer	0.00192	0.00252	CbGeAlD
Propiomazine—HTR2A—central nervous system—brain cancer	0.00175	0.0023	CbGeAlD
Propiomazine—HTR2A—cerebellum—brain cancer	0.00171	0.00225	CbGeAlD
Propiomazine—HRH1—brain—brain cancer	0.00167	0.00219	CbGeAlD
Propiomazine—HTR2A—brain—brain cancer	0.00139	0.00183	CbGeAlD
Propiomazine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	6.41e-05	0.000313	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—IL2—brain cancer	6.36e-05	0.000311	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—VAV1—brain cancer	6.34e-05	0.00031	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IRS2—brain cancer	6.34e-05	0.00031	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—IL2—brain cancer	6.27e-05	0.000306	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—VAV1—brain cancer	6.24e-05	0.000305	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—VAV1—brain cancer	6.23e-05	0.000304	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—VAV1—brain cancer	6.21e-05	0.000303	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—VAV1—brain cancer	6.19e-05	0.000302	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HES1—brain cancer	6.18e-05	0.000302	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—VAV1—brain cancer	6.13e-05	0.000299	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—VAV1—brain cancer	6.11e-05	0.000299	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IRS2—brain cancer	6.04e-05	0.000295	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—IL2—brain cancer	5.99e-05	0.000293	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IRS2—brain cancer	5.96e-05	0.000291	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PIK3CG—brain cancer	5.93e-05	0.00029	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—APC—brain cancer	5.93e-05	0.00029	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HES1—brain cancer	5.92e-05	0.000289	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	5.89e-05	0.000288	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—APC—brain cancer	5.85e-05	0.000286	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	5.85e-05	0.000286	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	5.73e-05	0.00028	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SPP1—brain cancer	5.71e-05	0.000279	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	5.63e-05	0.000275	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—APC—brain cancer	5.6e-05	0.000274	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	5.6e-05	0.000274	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SPP1—brain cancer	5.47e-05	0.000267	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HES1—brain cancer	5.46e-05	0.000267	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—IL2—brain cancer	5.44e-05	0.000266	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—EGFR—brain cancer	5.4e-05	0.000264	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HES1—brain cancer	5.37e-05	0.000262	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HES1—brain cancer	5.36e-05	0.000262	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HES1—brain cancer	5.34e-05	0.000261	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PIK3CG—brain cancer	5.34e-05	0.000261	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—APC—brain cancer	5.34e-05	0.000261	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—EGFR—brain cancer	5.33e-05	0.00026	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HES1—brain cancer	5.32e-05	0.00026	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—IL2—brain cancer	5.28e-05	0.000258	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HES1—brain cancer	5.27e-05	0.000258	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—APC—brain cancer	5.26e-05	0.000257	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	5.26e-05	0.000257	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HES1—brain cancer	5.26e-05	0.000257	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—IL2—brain cancer	5.2e-05	0.000254	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—IL2—brain cancer	5.2e-05	0.000254	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PDGFRA—brain cancer	5.19e-05	0.000254	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—IL2—brain cancer	5.19e-05	0.000253	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—IL2—brain cancer	5.17e-05	0.000253	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IRS2—brain cancer	5.17e-05	0.000253	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—IL2—brain cancer	5.15e-05	0.000252	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	5.11e-05	0.00025	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—IL2—brain cancer	5.1e-05	0.000249	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—EGFR—brain cancer	5.1e-05	0.000249	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PDGFRA—brain cancer	5.1e-05	0.000249	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	5.09e-05	0.000249	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	5.08e-05	0.000248	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	5.07e-05	0.000248	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SPP1—brain cancer	5.04e-05	0.000246	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	5.02e-05	0.000245	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	5e-05	0.000245	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SPP1—brain cancer	4.96e-05	0.000242	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SPP1—brain cancer	4.95e-05	0.000242	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IRS2—brain cancer	4.95e-05	0.000242	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SPP1—brain cancer	4.94e-05	0.000241	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SPP1—brain cancer	4.92e-05	0.00024	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SPP1—brain cancer	4.87e-05	0.000238	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—EGFR—brain cancer	4.86e-05	0.000238	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SPP1—brain cancer	4.86e-05	0.000237	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—IL2—brain cancer	4.8e-05	0.000234	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	4.8e-05	0.000234	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—IL2—brain cancer	4.72e-05	0.000231	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—IL2—brain cancer	4.71e-05	0.00023	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PIK3CG—brain cancer	4.7e-05	0.00023	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—IL2—brain cancer	4.7e-05	0.000229	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—IL2—brain cancer	4.68e-05	0.000229	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—IL2—brain cancer	4.64e-05	0.000227	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—RELA—brain cancer	4.63e-05	0.000226	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—IL2—brain cancer	4.62e-05	0.000226	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—ERBB2—brain cancer	4.6e-05	0.000225	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—RELA—brain cancer	4.57e-05	0.000223	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	4.56e-05	0.000223	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—APC—brain cancer	4.56e-05	0.000223	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IRS2—brain cancer	4.56e-05	0.000223	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—ERBB2—brain cancer	4.54e-05	0.000222	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IRS2—brain cancer	4.49e-05	0.000219	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IRS2—brain cancer	4.48e-05	0.000219	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IRS2—brain cancer	4.46e-05	0.000218	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IRS2—brain cancer	4.45e-05	0.000217	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IRS2—brain cancer	4.41e-05	0.000215	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IRS2—brain cancer	4.39e-05	0.000215	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—RELA—brain cancer	4.37e-05	0.000214	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—APC—brain cancer	4.37e-05	0.000213	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	4.37e-05	0.000213	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—ERBB2—brain cancer	4.35e-05	0.000212	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—IL2—brain cancer	4.17e-05	0.000204	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—RELA—brain cancer	4.17e-05	0.000204	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—EGFR—brain cancer	4.16e-05	0.000203	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ERBB2—brain cancer	4.14e-05	0.000202	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—IL2—brain cancer	4.11e-05	0.000201	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—RELA—brain cancer	4.11e-05	0.000201	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	4.09e-05	0.0002	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCND1—brain cancer	4.07e-05	0.000199	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—APC—brain cancer	4.03e-05	0.000197	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CG—brain cancer	4.03e-05	0.000197	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CTNNB1—brain cancer	4.03e-05	0.000197	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCND1—brain cancer	4.01e-05	0.000196	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	3.98e-05	0.000194	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	3.97e-05	0.000194	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—APC—brain cancer	3.96e-05	0.000194	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	3.96e-05	0.000194	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CG—brain cancer	3.95e-05	0.000193	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—APC—brain cancer	3.95e-05	0.000193	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	3.94e-05	0.000193	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—APC—brain cancer	3.94e-05	0.000193	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—IL2—brain cancer	3.94e-05	0.000193	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—APC—brain cancer	3.93e-05	0.000192	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	3.93e-05	0.000192	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—APC—brain cancer	3.89e-05	0.00019	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	3.89e-05	0.00019	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—APC—brain cancer	3.88e-05	0.00019	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	3.88e-05	0.00019	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCND1—brain cancer	3.84e-05	0.000188	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	3.8e-05	0.000186	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—IL2—brain cancer	3.75e-05	0.000183	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—IL2—brain cancer	3.7e-05	0.000181	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—EGFR—brain cancer	3.67e-05	0.000179	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCND1—brain cancer	3.66e-05	0.000179	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CTNNB1—brain cancer	3.62e-05	0.000177	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCND1—brain cancer	3.61e-05	0.000176	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—EGFR—brain cancer	3.61e-05	0.000176	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—EGFR—brain cancer	3.6e-05	0.000176	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—EGFR—brain cancer	3.59e-05	0.000175	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—EGFR—brain cancer	3.58e-05	0.000175	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	3.58e-05	0.000175	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—RELA—brain cancer	3.57e-05	0.000174	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—EGFR—brain cancer	3.55e-05	0.000173	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—VEGFA—brain cancer	3.54e-05	0.000173	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ERBB2—brain cancer	3.54e-05	0.000173	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	3.54e-05	0.000173	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—STAT3—brain cancer	3.51e-05	0.000171	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—VEGFA—brain cancer	3.5e-05	0.000171	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—STAT3—brain cancer	3.46e-05	0.000169	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—RELA—brain cancer	3.41e-05	0.000167	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	3.39e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—VEGFA—brain cancer	3.35e-05	0.000164	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—STAT3—brain cancer	3.32e-05	0.000162	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MYC—brain cancer	3.26e-05	0.000159	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MYC—brain cancer	3.22e-05	0.000157	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—IL2—brain cancer	3.21e-05	0.000157	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—VEGFA—brain cancer	3.19e-05	0.000156	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EGFR—brain cancer	3.19e-05	0.000156	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—STAT3—brain cancer	3.16e-05	0.000154	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	3.15e-05	0.000154	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—RELA—brain cancer	3.15e-05	0.000154	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EGFR—brain cancer	3.15e-05	0.000154	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCND1—brain cancer	3.13e-05	0.000153	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ERBB2—brain cancer	3.13e-05	0.000153	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—STAT3—brain cancer	3.12e-05	0.000152	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	3.1e-05	0.000152	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—RELA—brain cancer	3.1e-05	0.000151	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—RELA—brain cancer	3.09e-05	0.000151	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MYC—brain cancer	3.08e-05	0.000151	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—RELA—brain cancer	3.08e-05	0.000151	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ERBB2—brain cancer	3.08e-05	0.00015	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—IL2—brain cancer	3.07e-05	0.00015	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ERBB2—brain cancer	3.07e-05	0.00015	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—RELA—brain cancer	3.07e-05	0.00015	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ERBB2—brain cancer	3.06e-05	0.00015	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ERBB2—brain cancer	3.05e-05	0.000149	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—RELA—brain cancer	3.04e-05	0.000149	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—RELA—brain cancer	3.03e-05	0.000148	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ERBB2—brain cancer	3.02e-05	0.000148	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EGFR—brain cancer	3.01e-05	0.000147	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	3.01e-05	0.000147	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCND1—brain cancer	3e-05	0.000146	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	2.97e-05	0.000145	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—brain cancer	2.94e-05	0.000143	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—brain cancer	2.9e-05	0.000142	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EGFR—brain cancer	2.87e-05	0.00014	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—IL2—brain cancer	2.83e-05	0.000139	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EGFR—brain cancer	2.83e-05	0.000138	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—IL2—brain cancer	2.79e-05	0.000136	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—IL2—brain cancer	2.78e-05	0.000136	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—IL2—brain cancer	2.77e-05	0.000136	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—IL2—brain cancer	2.77e-05	0.000135	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCND1—brain cancer	2.76e-05	0.000135	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—IL2—brain cancer	2.74e-05	0.000134	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CTNNB1—brain cancer	2.74e-05	0.000134	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—IL2—brain cancer	2.73e-05	0.000133	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—VEGFA—brain cancer	2.73e-05	0.000133	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCND1—brain cancer	2.72e-05	0.000133	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCND1—brain cancer	2.71e-05	0.000133	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCND1—brain cancer	2.7e-05	0.000132	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—STAT3—brain cancer	2.7e-05	0.000132	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCND1—brain cancer	2.7e-05	0.000132	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	2.69e-05	0.000132	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CTNNB1—brain cancer	2.69e-05	0.000131	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	2.68e-05	0.000131	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—brain cancer	2.68e-05	0.000131	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCND1—brain cancer	2.67e-05	0.00013	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	2.67e-05	0.00013	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCND1—brain cancer	2.66e-05	0.00013	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	2.64e-05	0.000129	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—brain cancer	2.64e-05	0.000129	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	2.64e-05	0.000129	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	2.61e-05	0.000128	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—STAT3—brain cancer	2.59e-05	0.000126	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—brain cancer	2.53e-05	0.000124	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—brain cancer	2.51e-05	0.000123	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EGFR—brain cancer	2.46e-05	0.00012	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—brain cancer	2.41e-05	0.000118	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—VEGFA—brain cancer	2.41e-05	0.000118	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—brain cancer	2.4e-05	0.000117	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—STAT3—brain cancer	2.39e-05	0.000117	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—brain cancer	2.38e-05	0.000116	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—VEGFA—brain cancer	2.37e-05	0.000116	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—VEGFA—brain cancer	2.37e-05	0.000116	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—VEGFA—brain cancer	2.36e-05	0.000115	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EGFR—brain cancer	2.35e-05	0.000115	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.35e-05	0.000115	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—STAT3—brain cancer	2.35e-05	0.000115	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—STAT3—brain cancer	2.34e-05	0.000114	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—STAT3—brain cancer	2.33e-05	0.000114	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—VEGFA—brain cancer	2.33e-05	0.000114	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—STAT3—brain cancer	2.33e-05	0.000114	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	2.32e-05	0.000113	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—STAT3—brain cancer	2.3e-05	0.000113	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—STAT3—brain cancer	2.3e-05	0.000112	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—brain cancer	2.22e-05	0.000108	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—brain cancer	2.18e-05	0.000107	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—brain cancer	2.18e-05	0.000106	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—brain cancer	2.17e-05	0.000106	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EGFR—brain cancer	2.17e-05	0.000106	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—brain cancer	2.16e-05	0.000106	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—brain cancer	2.14e-05	0.000105	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—brain cancer	2.14e-05	0.000104	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EGFR—brain cancer	2.13e-05	0.000104	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EGFR—brain cancer	2.13e-05	0.000104	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EGFR—brain cancer	2.12e-05	0.000104	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EGFR—brain cancer	2.11e-05	0.000103	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EGFR—brain cancer	2.09e-05	0.000102	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.09e-05	0.000102	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—brain cancer	2.06e-05	0.000101	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—brain cancer	1.97e-05	9.65e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—brain cancer	1.82e-05	8.89e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—brain cancer	1.79e-05	8.75e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—brain cancer	1.79e-05	8.73e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—brain cancer	1.78e-05	8.7e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—brain cancer	1.78e-05	8.68e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—brain cancer	1.76e-05	8.59e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—brain cancer	1.75e-05	8.57e-05	CbGpPWpGaD
